Medscape July 18, 2024
Miriam E. Tucker

TOPLINE:

Over the past 20 years in Denmark, the incidence of type 2 diabetes-related outcomes and many treatment-related harms have both decreased without increased medication expenses despite an aging and more comorbid population; however, challenges remain.

METHODOLOGY:

  • Analysis of data from n = 461,805 individuals in the Danish population with type 2 diabetes between 2002 and 2020.
  • Multivariate analyses adjusted for potential confounders, including age, sex, and socioeconomic status.

TAKEAWAY

  • The population grew 2.7-fold from 2002 to 2020 (n = 113,105 to 306,962), the median age increased from 66 to 68 years, and the mean number of diseases per person increased from 5.2 to 8.8, with an increase in Charlson Comorbidity Index from 1.78 to 1.93.
  • After...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Patient / Consumer, Provider, Trends
AI tool helps find life-saving medicine for rare disease
Radiology business advocates’ top 5 priorities in Washington
Employers Reap $190 for Every $100 Invested in Behavioral Health
Calling patients at their home
Affineon Health Raises $5M for AI-Powered Physician Inbox Management

Share This Article